Skip to main content
. 2023 May 17;55(4):1104–1112. doi: 10.4143/crt.2023.502

Fig. 1.

Fig. 1

Study design. CTx, chemotherapy; fx, fraction; HNSCC, head and neck squamous cell carcinoma; Q4W, every 4 weeks.